Literature DB >> 26202253

Alteration of Mature Nucleocapsid and Enhancement of Covalently Closed Circular DNA Formation by Hepatitis B Virus Core Mutants Defective in Complete-Virion Formation.

Xiuji Cui1, Laurie Luckenbaugh1, Volker Bruss2, Jianming Hu3.   

Abstract

UNLABELLED: Assembly of hepatitis B virus (HBV) begins with packaging of the pregenomic RNA (pgRNA) into immature nucleocapsids (NC), which are converted to mature NCs containing the genomic relaxed circular (RC) DNA as a result of reverse transcription. Mature NCs have two alternative fates: (i) envelopment by viral envelope proteins, leading to secretion extracellularly as virions, or (ii) disassembly (uncoating) to deliver their RC DNA content into the host cell nucleus for conversion to the covalently closed circular (CCC) DNA, the template for viral transcription. How these two alternative fates are regulated remains to be better understood. The NC shell is composed of multiple copies of a single viral protein, the HBV core (HBc) protein. HBc mutations located on the surface of NC have been identified that allow NC maturation but block its envelopment. The potential effects of some of these mutations on NC uncoating and CCC DNA formation have been analyzed by transfecting HBV replication constructs into hepatoma cells. All envelopment-defective HBc mutations tested were competent for CCC DNA formation, indicating that core functions in envelopment and uncoating/nuclear delivery of RC DNA were genetically separable. Some of the envelopment-defective HBc mutations were found to alter specifically the integrity of mature, but not immature, NCs such that RC DNA became susceptible to nuclease digestion. Furthermore, CCC DNA formation could be enhanced by NC surface mutations that did or did not significantly affect mature NC integrity, indicating that the NC surface residues may be closely involved in NC uncoating and/or nuclear delivery of RC DNA. IMPORTANCE: Hepatitis B virus (HBV) infection is a major health issue worldwide. HBV assembly begins with the packaging into immature nucleocapsids (NCs) of a viral RNA pregenome, which is converted to the DNA genome in mature NCs. Mature NCs are then selected for envelopment and secretion as complete-virion particles or, alternatively, can deliver their DNA to the host cell nucleus to maintain the viral genome as nuclear episomes, which are the basis for virus persistence. Previous studies have identified mutations on the capsid surface that selectively block NC envelopment without affecting NC maturation. We have now discovered that some of the same mutations result in preferential alteration of mature NCs and increased viral nuclear episomes. These findings provide important new insights into the regulation of the two alternative fates of mature NCs and suggest new ways to perturb viral persistence by manipulating levels of viral nuclear episomes.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26202253      PMCID: PMC4577893          DOI: 10.1128/JVI.01481-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  Core protein phosphorylation modulates pregenomic RNA encapsidation to different extents in human and duck hepatitis B viruses.

Authors:  E V Gazina; J E Fielding; B Lin; D A Anderson
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  Polymerase gene products of hepatitis B viruses are required for genomic RNA packaging as wel as for reverse transcription.

Authors:  R C Hirsch; J E Lavine; L J Chang; H E Varmus; D Ganem
Journal:  Nature       Date:  1990-04-05       Impact factor: 49.962

3.  Regulation of hepadnavirus reverse transcription by dynamic nucleocapsid phosphorylation.

Authors:  Suresh H Basagoudanavar; David H Perlman; Jianming Hu
Journal:  J Virol       Date:  2006-11-29       Impact factor: 5.103

4.  Mutations affecting hepadnavirus plus-strand DNA synthesis dissociate primer cleavage from translocation and reveal the origin of linear viral DNA.

Authors:  S Staprans; D D Loeb; D Ganem
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

5.  Visualization of a 4-helix bundle in the hepatitis B virus capsid by cryo-electron microscopy.

Authors:  J F Conway; N Cheng; A Zlotnick; P T Wingfield; S J Stahl; A C Steven
Journal:  Nature       Date:  1997-03-06       Impact factor: 49.962

6.  Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification.

Authors:  J Summers; P M Smith; A L Horwich
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

7.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

8.  Genetically altering the thermodynamics and kinetics of hepatitis B virus capsid assembly has profound effects on virus replication in cell culture.

Authors:  Zhenning Tan; Megan L Maguire; Daniel D Loeb; Adam Zlotnick
Journal:  J Virol       Date:  2013-01-02       Impact factor: 5.103

9.  Phosphorylation and nuclear localization of the hepatitis B virus core protein: significance of serine in the three repeated SPRRR motifs.

Authors:  W Liao; J H Ou
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

10.  Serine phosphoacceptor sites within the core protein of hepatitis B virus contribute to genome replication pleiotropically.

Authors:  Eric B Lewellyn; Daniel D Loeb
Journal:  PLoS One       Date:  2011-02-15       Impact factor: 3.240

View more
  25 in total

1.  Identification of an Intermediate in Hepatitis B Virus Covalently Closed Circular (CCC) DNA Formation and Sensitive and Selective CCC DNA Detection.

Authors:  Jun Luo; Xiuji Cui; Lu Gao; Jianming Hu
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

Review 2.  Hepatitis B virus cccDNA: Formation, regulation and therapeutic potential.

Authors:  Yuchen Xia; Haitao Guo
Journal:  Antiviral Res       Date:  2020-05-22       Impact factor: 5.970

3.  Capsid Phosphorylation State and Hepadnavirus Virion Secretion.

Authors:  Xiaojun Ning; Suresh H Basagoudanavar; Kuancheng Liu; Laurie Luckenbaugh; Duoqian Wei; Chunyan Wang; Bo Wei; Yingren Zhao; Taotao Yan; William Delaney; Jianming Hu
Journal:  J Virol       Date:  2017-04-13       Impact factor: 5.103

4.  Naturally occurring core protein mutations compensate for the reduced replication fitness of a lamivudine-resistant HBV isolate.

Authors:  Yongmei Zhang; Hu Zhang; Junjie Zhang; Jiming Zhang; Haitao Guo
Journal:  Antiviral Res       Date:  2019-03-19       Impact factor: 5.970

5.  Conserved Lysine Residues of Hepatitis B Virus Core Protein Are Not Required for Covalently Closed Circular DNA Formation.

Authors:  Xupeng Hong; Jianming Hu
Journal:  J Virol       Date:  2022-07-18       Impact factor: 6.549

Review 6.  Revisiting Hepatitis B Virus: Challenges of Curative Therapies.

Authors:  Jianming Hu; Ulrike Protzer; Aleem Siddiqui
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

7.  Viral DNA-Dependent Induction of Innate Immune Response to Hepatitis B Virus in Immortalized Mouse Hepatocytes.

Authors:  Xiuji Cui; Daniel N Clark; Kuancheng Liu; Xiao-Dong Xu; Ju-Tao Guo; Jianming Hu
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

Review 8.  Virological Basis for the Cure of Chronic Hepatitis B.

Authors:  Jin Hu; Junjun Cheng; Liudi Tang; Zhanying Hu; Yue Luo; Yuhuan Li; Tianlun Zhou; Jinhong Chang; Ju-Tao Guo
Journal:  ACS Infect Dis       Date:  2018-06-25       Impact factor: 5.084

Review 9.  Targeting the multifunctional HBV core protein as a potential cure for chronic hepatitis B.

Authors:  Usha Viswanathan; Nagraj Mani; Zhanying Hu; Haiqun Ban; Yanming Du; Jin Hu; Jinhong Chang; Ju-Tao Guo
Journal:  Antiviral Res       Date:  2020-08-17       Impact factor: 5.970

10.  Common and Distinct Capsid and Surface Protein Requirements for Secretion of Complete and Genome-Free Hepatitis B Virions.

Authors:  Xiaojun Ning; Laurie Luckenbaugh; Kuancheng Liu; Volker Bruss; Camille Sureau; Jianming Hu
Journal:  J Virol       Date:  2018-06-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.